Literature DB >> 17072569

[Innovative care models for treating psychosis].

W Rössler1, A Theodoridou.   

Abstract

It is generally accepted that modern mental health care gives community treatment priority over partial or full inpatient treatment. The requirements for community treatment of severely ill and chronic psychiatric patients are complex and, together with financing by the different social insurance providers, may lead to a rather problematic fragmentation of health service supply. Schizophrenia is considered the most expensive mental illness in Germany. It is estimated that indirect costs (expressed in financial terms) are five times higher than the direct costs of treatment and care. Innovative concepts of psychosocial intervention show that case management and assertive community treatment reduce the hospitalisation rate and duration of inpatient treatment, enhance social integration, and find the approval of most patients. However, there is no empirical evidence supporting this "psychiatry with no beds". Consideration should be given to psychosocial interventions as an alternative to inpatient hospital treatment such as day hospital care, crisis houses, or acute home treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17072569     DOI: 10.1007/s00115-006-2192-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  11 in total

Review 1.  Supported employment: evidence for an evidence-based practice.

Authors:  Gary R Bond
Journal:  Psychiatr Rehabil J       Date:  2004

2.  [The International Classification of Functioning, Disability and Health].

Authors:  M Seidel
Journal:  Nervenarzt       Date:  2005-01       Impact factor: 1.214

Review 3.  WITHDRAWN: Assertive community treatment for people with severe mental disorders.

Authors:  Max Marshall; Austin Lockwood
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

4.  Intensive versus standard case management for severe psychotic illness: a randomised trial. UK 700 Group.

Authors:  T Burns; F Creed; T Fahy; S Thompson; P Tyrer; I White
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

Review 5.  Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality.

Authors:  P Tyrer; J Coid; S Simmonds; P Joseph; S Marriott
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 6.  Crisis intervention for people with severe mental illnesses.

Authors:  C B Joy; C E Adams; K Rice
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Integration of psychiatric and vocational services: a multisite randomized, controlled trial of supported employment.

Authors:  Judith A Cook; Anthony F Lehman; Robert Drake; William R McFarlane; Paul B Gold; H Stephen Leff; Crystal Blyler; Marcia G Toprac; Lisa A Razzano; Jane K Burke-Miller; Laura Blankertz; Michael Shafer; Susan A Pickett-Schenk; Dennis D Grey
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 8.  [Cognitive remediation. A new chance in rehabilitation of schizophrenic disorders?].

Authors:  R Vauth; M Dietl; R D Stieglitz; H M Olbrich
Journal:  Nervenarzt       Date:  2000-01       Impact factor: 1.214

9.  Does treatment delay in first-episode psychosis really matter?

Authors:  S M Harrigan; P D McGorry; H Krstev
Journal:  Psychol Med       Date:  2003-01       Impact factor: 7.723

10.  The cost of comprehensive care of people with schizophrenia living in the community. A cost evaluation from a German catchment area.

Authors:  H J Salize; W Rössler
Journal:  Br J Psychiatry       Date:  1996-07       Impact factor: 9.319

View more
  2 in total

1.  Prevention of rehospitalization in schizophrenia: results of an integrated care project in Germany.

Authors:  Christian Schmidt-Kraepelin; Birgit Janssen; Wolfgang Gaebel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

Review 2.  [Treatment of chronic psychiatric disorders. Ethical and anthropological aspects].

Authors:  J Valdes-Stauber
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.